ZYDUSLIFE.NS

Zydus Lifesciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,070.80

-0.34%Jun 19, 2026

AI Brief

Market cap

$1.08T

52w range

—

P / E

—

EPS · FY 2026

$50.09

Volume

—

Revenue · FY 2026

$271.48B

+16.81% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Zydus Lifesciences Limited’s valuation

News pulse · 14d

1 stories—All news →

06-20today

Zydus Lifesciences Limited Bonds — Corporate Bond Rates - TradingView1d

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1070.80

Change

+12.47%

Period high

$1105.90

Period low

$860.60

Period start

$952.102025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$1,119.59

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

ZYDUSLIFE.NS

1,071+12.47%

H 1,120L 835.50MA50 999.48MA200 954.82Avg vol 975K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Jun 2025	$65.74B	$14.67B	$14.58

Sector & industry today

Live

Sectors

Technology
+2.51%
Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Consumer Defensive
-0.30%
Energy
-0.45%
Industrials
-0.48%
Basic Materials
-0.66%
Financial Services
-0.67%
Real Estate
-0.99%
Healthcare
-1.51%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-1.01%
Oil & Gas Energy
+8.53%
Business Equipment & Supplies
+5.82%
Semiconductors
+5.24%
Electronic Gaming & Multimedia
+5.23%
Advertising Agencies
-5.20%
Medical - Equipment & Services
+5.08%
Grocery Stores
-4.35%
Financial - Mortgages
+4.08%
Broadcasting
+4.00%
Computer Hardware
-3.67%
Internet Content & Information
+3.58%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Zydus Lifesciences Limited Bonds — Corporate Bond Rates - TradingView
news.google.com·Jun 20, 2026

Peers

No peer list available for ZYDUSLIFE.NS.

Total assets

$524.07B

Total debt

$124.96B

Cash & equiv

$14.17B

Operating CF

$21.91B

Free cash flow

-$12.03B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$271.48B	$57.87B	$50.4B	$50.09	+18.56%
FY 2025	$232.42B	$96.04B	$45.26B	$44.97	+19.47%
FY 2024	$195.47B	$75.96B	$38.6B	$37.91	+19.74%